The head of PhRMA and representatives from Pfizer and Amgen met with President Trump behind closed doors “as industry lobbyists ramped up efforts to kill administration plans intended to lower drug prices.” ... Read More

Rokita’s past statements disqualify him from public office WASHINGTON – Today, the Senate Commerce Committee will hold a hearing on ... Read More

Disclosure Shows PhRMA Spent a Record $16.1 Million Lobbying in First Half of 2019 WASHINGTON — Newly posted disclosures on ... Read More

Ross’ Leadership Absent Amid Global Trade Crisis and Census Catastrophe WASHINGTON — Today, POLITICO provided new insight into the chaos ... Read More